Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

This article has a correction. Please see:

Corrections - August 01, 2011

Letter

Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis

Authors

V Bejarano PubMed articles Google scholar articles
P G Conaghan PubMed articles Google scholar articles
S M Proudman PubMed articles Google scholar articles
M H Buch PubMed articles Google scholar articles
A K Brown PubMed articles Google scholar articles
P Emery PubMed articles Google scholar articles

Professor P Emery, Academic Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, Chapel Allerton Hospital, Chapeltown Road, Leeds LS7 4SA, UK; p.emery{at}leeds.ac.uk

Citation

Bejarano V, Conaghan PG, Proudman SM, et al

Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis

Annals of the Rheumatic Diseases 2009;68:761-763.

Publication history

Accepted August 3, 2008
First published April 14, 2009.

Online issue publication

October 31, 2019

Copyright information

2009 BMJ Publishing Group and European League Against Rheumatism